Increased disease activity in eNOS-deficient mice in experimental colitis

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Experimental colitis models mimic human inflammatory bowel disease (IBD).
• Nitric oxide synthases (NOS) are implicated in IBD pathogenesis.
• The specific role of endothelial nitric oxide synthase (eNOS) in IBD remains unclear.

Purpose of the Study:

• To investigate the role of endothelial nitric oxide synthase (eNOS) in dextran sodium sulfate (DSS)-induced experimental colitis.
• To compare disease severity in wild-type (eNOS+/+) and eNOS-deficient (eNOS-/-) mice.

Main Methods:

• Induction of experimental colitis using 3% dextran sodium sulfate (DSS) in drinking water.
• Comparison of disease activity, weight loss, stool blood, and histopathology between eNOS+/+ and eNOS-/- mice.
• Assessment of leukocyte infiltration and MAdCAM-1 expression in the gut tissue.

Main Results:

• DSS administration induced colitis in both mouse strains.
• eNOS-deficient mice exhibited significantly increased disease activity compared to wild-type controls.
• Histological analysis revealed greater gut injury, leukocyte infiltration, and MAdCAM-1 expression in eNOS-/- mice.

Conclusions:

• Endothelial nitric oxide synthase (eNOS) plays a protective role in limiting intestinal injury during experimental colitis.
• eNOS deficiency exacerbates colitis severity.
• Altered eNOS activity may contribute to the pathogenesis of human inflammatory bowel disease.